Urinalysis is a urine analysis test that aids in the detection of a wide range of disorders such as diabetes, kidney disease, and urinary tract infection. Its primary goal is to keep track of health conditions. Urinalysis is performed as part of a routine medical check-up, as part of pre-surgery preparation, as part of a pregnancy check-up, or as part of a hospital admission to treat a variety of disorders. It also aids in determining the source of symptoms such as back pain, abdominal pain, and painful urination. The rising prevalence of kidney diseases, the implementation of PPACA, and an increase in the geriatric population are all factors driving the global urinalysis market. However, the implementation of an excise tax by the US government, as well as stringent regulatory procedures, are factors impeding market growth.
The growing geriatric population in developed and developing regions will drive the Urinalysis Market forward. The prevalence of age-related diseases such as diabetes, liver, and kidney disease is expected to rise significantly due to rapid growth in the senior population. The increasing number of prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin is due to the diagnosis and management of such diseases. Urinalysis is used to perform these tests, so it is expected to have a positive impact on the market. Developing economies such as India, South Korea, Brazil, and Mexico are expected to provide potential growth opportunities for major urinalysis market players.
Read More@ https://bit.ly/3tsF4qL
